A new publication by Abbas Zaidi published this week in the AHA Circulation journal, has garnered attention for its study of the “Physiological right ventricular adaption in elite athletes of African and Afro-Caribbean origin”.
Featured as “Editors pick of the week”, the publication has also spurned an article from Johnathan Weinstock and Mark Estes who have comended the authors for bringing to the forefront the “important clinical implication”s of this trial, and the emphasis that should be placed upon them.
Essential read for all clinicians involved in managing patients with chest pain or those that should be aware of non-cardiac chest pain
Extensive use of practical case-based material and review of guidelines in a broad multidisciplinary manner
The condition known as “chest pain with normal coronary arteries” or “cardiac syndrome X” has puzzled physicians since the advent of coronary arteriography. Although epicardial coronary artery spasm, as seen in Prinzmetal’s variant angina, explains a proportion of cases of typical chest pain despite normal coronary arteriograms, many patients who seek medical attention for exertional and rest angina in the absence of obstructive coronary artery disease are not variant angina cases. This syndrome therefore constitutes both a diagnostic and therapeutic challenge
Dr Narains revolutionary project to offer free early diagnoses for inherited heart conditions, has received glowing praise and a mention in the Hindustan Times last month.
The project aims to test for early signs of heart disease such as cardiomyopathy, that may be the root cause of sudden cardiac death instances in the region. The screening tested hundreds of patient under 35, for any signs of inherited or early heart disease. Beginning in Patna, and later moving to other parts of the globe, the screening was offered free of charge under humanitarian grounds. The team, headed up by Dr Narain, screened the patients using an ECG machine. If neccessary they were then offered a further Echo scan, overseen by the highly experienced Cardiology unit at St George’s hospital, London.
The 3rd Annual Scientific Meeting of the CVSRC 2012- Lipids and Lipoproteins was held on the 29th November 2012 at The Royal Society of Medinine in London. The focus for this years conference was onn lipds and lipoproteins. Lipid disorders remian one of the largest treatavble risks seen by the centre in the treatment and diagnosis of atherosclerotic cardiovascular disease.
The highlights from the confwerence can be seen in the recordings below. Our next meeting will be on 9th December 2013, with the programme to be announced shortly. You can pre-register for this event by following the link on our site.
Introduction from Prof. Kaski and talk by Dr Cockerill on HDL
Prof. Von Eckardstein discussing proteomics and lipidomics of HDL and its subfractions
Prof. Packard discusses CETP inhibition as a target for CHD prevention
Prof. Ray discusses statins and diabetes risk
Prof. Badimon discusses coronary artery disease and HDL
Prof. Luscher discusses HDL-Cholesterol
Dr. Wierzbicki discusses LDL reduction beyond statins